The impact of missing values in the concentration-time curve on the assessment of bioequivalence-Reference-Cited by-同舟云学术

The impact of missing values in the concentration-time curve on the assessment of bioequivalence

Published:2005 Issue:2 Volume:4 Page:91-99
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceut. Statist.

Author:

Donner Allan,Hauck Walter W.,Zou Guangyong

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Reference5 articles.

1. OPTIMAL SAMPLING TIMES IN BIOEQUIVALENCE TESTS

2. Design and analysis of bioavailability and bioequivalence studies. Marcel Dekker: New York, 1992.

3. Health and Welfare Canada. Drugs directorate guidelines: conduct and analysis of bioavailability and bioequivalence studies. Ottawa, Ontario, 1992.

4. A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved GSimp: A Flexible Missing Value Imputation Method to Support Regulatory Bioequivalence Assessment;Annals of Biomedical Engineering;2022-09-15

2. Likelihood-based inferences about the mean area under a longitudinal curve in the presence of observations subject to limits of detection;Pharmaceutical Statistics;2015-04-01

3. Importance of protocols for simulation studies in clinical drug development;Statistical Methods in Medical Research;2010-08-05

4. Structure evolution of carbon black under ionic-liquid-assisted microwave irradiation;Applied Surface Science;2009-07

5. A New Approach for Outliers in a Bioavailability/Bioequivalence Study;Journal of Biopharmaceutical Statistics;2007-05-01